News
The decision amounts to a termination of 22 mRNA vaccine development contracts, totaling nearly $500 million in investment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback